Background: liver haemangioma considered as the commonest benign lesion. Diagnosis mainly done incidentally during abdominal ultrasound (US). Giant haemangioma describe mass more than 5cm. But some authors considered giant more than 10cm. Most of the haemangiomas are asymptomatic which requires only follow up. Surgery is an option when patient start to complain or for fear of its rupture. Two methods used for surgical management either enucleation or liver resection. Patients and Methods: Between 2014 and 2018 we managed twenty-two patients diagnosed as giant haemangioma, study design was a retrospective held in Hepato-Biliary centre, General Surgery Department, Zagazig, Egypt. Results: Nine patients manged via surgical resection, while in the other thirteen patient’s enucleation was the chosen procedures. We found no mortality and during follow up no de-novo lesions appeared. Conclusion: surgical intervention for symptomatic giant haemangioma is the optimal chosen management procedure. There is no specific size to choose surgery for haemangioma management, but giant haemangioma is prone to complicate, so prophylactic surgery sometimes is an option. Morbidity and mortality incidence decreased after liver surgery improvement.
Mansy, W. (2024). Surgical Management of Hepatic Haemangioma. A Centre Experience.. Zagazig University Medical Journal, 30(1.1), 178-182. doi: 10.21608/zumj.2021.62213.2128
MLA
Wael Salah Eldin Mansy. "Surgical Management of Hepatic Haemangioma. A Centre Experience.", Zagazig University Medical Journal, 30, 1.1, 2024, 178-182. doi: 10.21608/zumj.2021.62213.2128
HARVARD
Mansy, W. (2024). 'Surgical Management of Hepatic Haemangioma. A Centre Experience.', Zagazig University Medical Journal, 30(1.1), pp. 178-182. doi: 10.21608/zumj.2021.62213.2128
VANCOUVER
Mansy, W. Surgical Management of Hepatic Haemangioma. A Centre Experience.. Zagazig University Medical Journal, 2024; 30(1.1): 178-182. doi: 10.21608/zumj.2021.62213.2128